Engineers from the National University of Singapore plan to further develop the sensor to continuously monitor mental health ...
StockStory.org on MSN
Winners and losers of Q4: Insulet (NASDAQ:PODD) vs the rest of the patient monitoring stocks
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the patient monitoring stocks, including Insulet ...
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, ...
Parkman Healthcare Partners initiated a 200,000-share stake in Masimo during the fourth quarter. The quarter-end position value rose by $26.01 million as a result. Masimo is not among the fund's top ...
StockStory.org on MSN
Unpacking Q4 earnings: ResMed (NYSE:RMD) in the context of other patient monitoring stocks
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...
Discover how MiniMed's full-stack diabetes technology and global reach post-IPO could transform a rapidly growing $18B ...
DelveInsight's Diabetes Care Devices Market Insights report provides the current and forecast market analysis, individual leading diabetes care devices companies' market shares, challenges, diabetes ...
Add Yahoo as a preferred source to see more of our stories on Google. Dexcom is poised to share new data on the benefits of its continuous glucose monitoring technology (CGM), which the company says ...
DexCom, Inc. DXCM is well positioned for growth in the coming quarters, supported by the significant potential of the continuous glucose monitoring (CGM) market. A strong fourth-quarter 2025 ...
BARCELONA, Spain--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, will present new findings that showcase the benefits of its glucose biosensing technology for ...
NEW YORK, NY, UNITED STATES, April 3, 2026 /EINPresswire.com/ -- The IoT healthcare market reached $176 billion in 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results